Trial Profile
Retrospective chart review investigating comparative efficacy between everolimus-based therapy versus endocrine monotherapy in post menopausal women with HR+/HER2- metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 05 Feb 2016 New trial record